News

BMJ2d
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Along these lines, the European League Against Rheumatism (EULAR) has recently formulated major objectives, which among other aspects specify that “by 2012, EULAR will have provided standards of care ...
BMJ3d
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
This first update of the ASAS/EULAR recommendations on the management of ankylosing spondylitis (AS) is based on the original paper, a systematic review of existing recommendations and the literature ...
rmdopen.bmj3d
Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
Objective To examine the performance of the new 2022 American College of Rheumatology (ACR)/EULAR giant cell arteritis (GCA) classification criteria for diagnosis in routine clinical care. Methods ...
rmdopen.bmj5d
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage
Objective Subjects with subclinical psoriatic arthritis (PsA), defined as the presence of arthralgia in psoriasis (PsO), are at higher risk of PsA but scant real-world data exist. Our aims were to (1) ...
lupus.bmj5d
608 Utility 2019 EULAR/ACR SLE criteria to re-classify patients with interstitial pneumonia with autoimmune features as SLE with interstitial lung disease
In 2019, the European Alliance of Association of Rheumatology/American College of Rheumatology (EULAR/ACR) published updated criteria for SLE with similar sensitivity but higher specificity than the ...